David Moadel

David Moadel

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Hyliion Isn’t an EV Market Superstar Yet, but Its Day Will Come

Among the array of EV investments on the market today, HYLN stock isn't the most popular. For true contrarians, that's not a bad thing.

Record Revenue Performance Makes a Strong Case for Hexo Stock

You might see folks buzzing about the HEXO stock reverse split. That's important, but the real headline is Hexo's financial performance.

Don’t Let This Run-Up in PayPal Stock Stop You From Joining the Party

The bulls have bid PayPal stock up to incredible heights in 2020. And, the e-commerce explosion indicates that more gains could be coming.

There’s Likely Much More Upside in Store for Lemonade

The skeptics have been wrong about LMND stock so far, and permanent changes to the insurance market suggest that more gains are coming.

As Bitcoin Targets $25K and More, It’s Okay to Add but Avoid Crypto FOMO

It's encouraging to witness key milestones being achieved with Bitcoin, but over-leveraging ourselves can lead to disastrous results.

After Its Recent Decline, Xpeng Stock Is a Viable EV Alternative

XPEV stock might not have the clout that surrounds other electric vehicle stocks, but the setup for much higher prices is there nonetheless.

Even Cannabis Market Bulls Should Be Wary of Sundial Growers

There are reasons to be bullish on the cannabis market generally. Yet, Sundial Growers stock isn't the right entry point into this industry.

As Ripple Rips, Crypto Bulls See Much More Room to Run

As traders and the media focus on Bitcoin's impressive price run, it's worthwhile to consider Ripple as a crypto super-runner in the making.

Don’t Let the Vaccine Trial Delay Stop You from Believing in Novavax

If you're concerned over a regulatory bump in the road, relax, as Novavax stock should still have catalysts to drive the share price higher.

With a Big Regulatory Win, Moderna Stock Is Worth Keeping

Even though Pfizer is the first-place finisher in the Covid-19 vaccine race, Moderna stock is worthwhile as there's room for two winners.